Onat Kadioglu
Overview
Explore the profile of Onat Kadioglu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
59
Citations
887
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Ooko E, Kadioglu O, Greten H, Efferth T
Front Pharmacol
. 2017 Feb;
8:38.
PMID: 28210221
has long been used in China and India as anti-inflammatory agent to treat a wide variety of conditions and also as a spice for varied curry preparations. The chemoprofile of...
32.
Kadioglu O, Cao J, Kosyakova N, Mrasek K, Liehr T, Efferth T
Sci Rep
. 2016 Nov;
6:36754.
PMID: 27824156
We systematically characterised multifactorial multidrug resistance (MDR) in CEM/ADR5000 cells, a doxorubicin-resistant sub-line derived from drug-sensitive, parental CCRF-CEM cells developed in vitro. RNA sequencing and network analyses (Ingenuity Pathway Analysis)...
33.
Ooko E, Alsalim T, Saeed B, Saeed M, Kadioglu O, Abbo H, et al.
Toxicol Appl Pharmacol
. 2016 Jun;
305:216-233.
PMID: 27318188
Background: Multidrug resistance (MDR) and drug transporter P-glycoprotein (P-gp) represent major obstacles in cancer chemotherapy. We investigated 19 synthetic curcumin derivatives in drug-sensitive acute lymphoblastic CCRF-CEM leukemia cells and their...
34.
Seo E, Saeed M, Law B, Wu A, Kadioglu O, Greten H, et al.
Molecules
. 2016 Apr;
21(4):496.
PMID: 27092478
Drug resistance and the severe side effects of chemotherapy necessitate the development of novel anticancer drugs. Natural products are a valuable source for drug development. Scopoletin is a coumarin compound,...
35.
Kadioglu O, Efferth T
Invest New Drugs
. 2016 Mar;
34(4):515-21.
PMID: 26972431
Bioinformatics screening and molecular docking analyses were utilized to select high affinity peptides targeting translationally controlled tumor protein (TCTP). Selected peptide aptamers were tested towards cancer cell lines with different...
36.
Kadioglu O, Jacob S, Bohnert S, Nass J, Saeed M, Khalid H, et al.
Phytomedicine
. 2016 Mar;
23(3):293-306.
PMID: 26969383
Background: Ziziphus spina-christi (L.) Desf. (Christ's Thorn Jujube) is a wild tree today found in Jordan, Israel, Egypt, and some parts of Africa, which was already in use as a...
37.
Efferth T, Banerjee M, Paul N, Abdelfatah S, Arend J, Elhassan G, et al.
Phytomedicine
. 2016 Mar;
23(2):166-73.
PMID: 26926178
Background: Biopiracy mainly focuses on the use of biological resources and/or knowledge of indigenous tribes or communities without allowing them to share the revenues generated out of economic exploitation or...
38.
Kadioglu O, Saeed M, Valoti M, Frosini M, Sgaragli G, Efferth T
Biochem Pharmacol
. 2016 Jan;
104:42-51.
PMID: 26807479
Rhodamine 123 (R123) transport substrate sensitizes P-glycoprotein (P-gp) to inhibition by compound 2c (cis-cis) N,N-bis(cyclohexanolamine)aryl ester isomer in a concentration-dependent manner in human MDR1-gene transfected mouse T-lymphoma L5178 cells as...
39.
Saeed M, Cao J, Fadul B, Kadioglu O, Khalid H, Yassin Z, et al.
Anticancer Res
. 2016 Jan;
36(1):279-86.
PMID: 26722054
Background: While cancer epidemiology is well-investigated in developed countries, the cancer burden in Africa is less well documented. We provide cancer statistics of 33,201 patients from all Sudan diagnosed at...
40.
Kadioglu O, Serly J, Seo E, Vincze I, Somlai C, Saeed M, et al.
Anticancer Res
. 2015 Dec;
35(12):6505-8.
PMID: 26637863
Copper transporter 1 (CTR1) represents an important determinant of cisplatin resistance. A series of 35 semi-substituted steroids were recently investigated on cisplatin-resistant CTR1-expressing A2780cis ovarian carcinoma cells as well as...